Talabostat Mesylate: A Precision Tool for DPP4 Inhibition...
2025-10-21
Talabostat mesylate (PT-100, Val-boroPro) empowers researchers to dissect and modulate the tumor microenvironment with unprecedented specificity through DPP4 and FAP inhibition. This comprehensive guide details experimental workflows, protocol enhancements, and troubleshooting strategies, ensuring reproducible results and translational relevance in cancer and immune modulation research.